Burning Rock Biotech Limited (BNR) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Burning Rock Biotech Limited (BNR) Earnings Overview
As of July 7, 2026, Burning Rock Biotech Limited (BNR) reported trailing twelve-month net income of -$55M, reflecting -47.3% year-over-year growth. The company earned $-52.83 per diluted share over the past four quarters, with a net profit margin of -10.3%.
Looking at the long-term picture, BNR's historical earnings data spans multiple years. The company achieved its highest annual net income of -$55M in fiscal 2025, representing a new all-time high.
Burning Rock Biotech Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), GH (-$433M net income, -42.4% margin), NTRA (-$226M net income, -9.0% margin), BNR has room to improve margins relative to the peer group. Compare BNR vs EXAS →
BNR Earnings vs Peers
Earnings metrics vs comparable public companies
BNR Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$55M | +84.0% | -$55M | $-49.60 | -10.3% | -10.2% |
| 2024 | -$347M | +47.0% | -$358M | $-33.67 | -67.2% | -69.3% |
| 2023 | -$654M | +32.7% | -$669M | $-63.84 | -121.6% | -124.5% |
| 2022 | -$971M | -21.9% | -$980M | $-93.47 | -172.4% | -174.1% |
| 2021 | -$797M | -95.6% | -$797M | $-76.45 | -156.9% | -156.9% |
| 2020 | -$407M | -141.9% | -$412M | $-68.76 | -94.7% | -95.9% |
| 2019 | -$168M | +5.2% | -$169M | $-142.30 | -44.1% | -44.3% |
| 2018 | -$177M | -35.2% | -$161M | $-103.82 | -85.0% | -77.3% |
| 2017 | -$131M | - | -$121M | $-102.02 | -118.1% | -108.7% |
Download Data
Export BNR earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BNR — Frequently Asked Questions
Quick answers to the most common questions about buying BNR stock.
What is BNR earnings per share (EPS)?
BNR trailing twelve-month (TTM) diluted EPS is $-52.83, reflecting -47.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Burning Rock Biotech Limited's net income?
Burning Rock Biotech Limited (BNR) trailing twelve-month net income is $-55M as of 2025. Earnings declined -47.3% year-over-year.
Is BNR profitable?
BNR is not currently profitable on a TTM basis, reporting a net loss of $-55M. Net margin is -10.3%. Investors should monitor for a return to profitability.
What is BNR's earnings growth rate?
BNR compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are BNR's profit margins?
Burning Rock Biotech Limited net profit margin is -10.3%, operating margin is -10.2%, and gross margin is +74.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -9.9%.
Is BNR growing earnings?
BNR earnings are declining — EPS fell -47.3% year-over-year. TTM net income dropped to $-55M. This contrasts with the 5-year CAGR of N/A.
What was BNR's best earnings year?
Burning Rock Biotech Limited's highest annual net income on record is $-55M, achieved in fiscal year 2025. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were BNR's earnings last quarter?
BNR's most recent reported quarter was Q4 2025. Net income was $-15M with diluted EPS of $-14.70. For a full breakdown of all quarters, see the quarterly earnings table on this page.